13 January 2014 | News | By BioSpectrum Bureau
Mr Hoppenot has stepped down to pursue a career opportunity outside Novartis
Singapore: Novartis oncology president, Mr HervÃ© Hoppenot, has stepped down from the position to pursue a career opportunity outside the organization.
Dr Alessandro Riva, Global Head, Novartis Oncology Development and Medical Affairs, will take on the role of President of Novartis Oncology ad interim, in addition to his current role, until a successor is named in due course.
HervÃ© has led the Oncology business since 2010.